Regulation of Lens Fiber Cell Structure and Function by Post Translational Modification of Intermediate Filaments
Regulation of Lens Fiber Cell Structure and Function by Post Translational Modification of Intermediate Filaments
批准号:
9900012
负责人:
PAUL Gillespie FITZGERALD
金额:
$39.25万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-01 至 2022-02-28
关键词:
AffectAgeAgingAntibodiesAppearanceAtomic Force MicroscopyBiological ModelsBiologyCaliberCaspaseCell Differentiation processCell MaturationCell physiologyCellsCellular StructuresChronologyClustered Regularly Interspaced Short Palindromic RepeatsCrystalline LensDataElectron MicroscopyEventGenesGenetic EngineeringGenetic TranscriptionHumanIntermediate Filament ProteinsIntermediate FilamentsLens FiberLifeLightLipidsMapsMasksMass Spectrum AnalysisMechanicsMediatingMitosisModelingModificationMolecularMusMutationNeonatalOpticsOrganellesOrganismPhenotypePhosphorylationPhosphorylation SitePost-Translational Modification SitePost-Translational Protein ProcessingProcessProtein BiosynthesisProteinsPublishingRegulationReportingResistanceResolutionRestSeriesSiteStructureSurfaceTestingThickTimeTissuesTranslatingTranslationsWorkZebrafishcell typeexperimental studyfiber celllensmechanical propertiesmouse modelmutantprogramsprotein functiontemporal measurement
中文摘要
项目摘要/摘要
人工晶状体是研究细胞和分子衰老的极佳模型。镜片是
排列成一系列同心的壳,每个壳有1个纤维细胞厚。晶状体在一生中都会生长
在现有壳的基础上添加新壳。因为细胞不会随着年龄的增长而丢失,所以贝壳
按照出生日期的确切时间顺序排列,最大的在中心,最小的在
表面。在人类身上,这大约是2500个同心壳。更值得注意的是,纤维细胞
仅保留它们的所有膜细胞器,直到它们完全形成新的壳为止,在
在这一点上他们被摧毁了。在人类的晶状体中,只有2500层中的100层左右
有细胞器。其他2400层不能合成蛋白质,它们的寿命是
没有蛋白质替代的有机体。尽管无法合成新的蛋白质、纤维
细胞经历了巨大的结构变化,远远超过了细胞器丢失的程度。
根据初步数据和之前发表的工作,我们假设这些
结构变化是由翻译后修饰(PTM)的过程推动的
晶状体特异的中间丝(IF)蛋白。我们假设这些PTM会改变
蛋白质的功能,然后协调结构的变化。晶状体生物学领域很有启发性
在缺乏生物合成能力的细胞中进行的大量类似的过程。我们
我相信这一建议至少可以直接检验因果关系(PTM)和结果(结构变化)
一组这样的更改,并以细胞级别的分辨率进行更改。成功完成这项工作
提案将建立一种机制,通过该机制,细胞可以影响可预测的
随着时间的推移,在没有蛋白质合成的情况下,结构会发生变化。要做到这一点,我们将确定
PTM,根据结构变化进行本地化,然后通过以下方式直接测试PTM的效果
利用CRISPR对斑马鱼IF PtM位点进行遗传修饰,然后将关键观察结果转化为
从斑马鱼,变成老鼠模型。
英文摘要
Project Summary/Abstract
The ocular lens is an excellent model in which to study cellular and molecular aging. The lens is
arranged as a series of concentric shells each 1 fiber cell thick. Lenses grow throughout life by
addition of new shells to existing shells. Because no cells are lost with age, the shells are
arranged in exact chronological order by birthdate, with the oldest at the center, and youngest at
the surface. In humans this is about 2,500 concentric shells. Even more remarkable, fiber cells
retain all their membranous organelles only until they complete formation of a new shell, at
which point they are destroyed. In human lenses, only the outer 100 or so of the 2,500 layers
has organelles. The other 2,400 layers are incapable of protein synthesis, and live the lifetime of
the organism without protein replacement. Despite the inability to synthesize new protein, fiber
cells undergo dramatic structural changes well past the point at which they have lost organelles.
On the basis of preliminary data, and previously published work, we hypothesize that these
structural changes are powered by a progression of post translational modifications (PTMs) to
lens-specific intermediate filament (IF) proteins. We hypothesize that these PTMs change
protein function which then orchestrates structural change. The field of lens biology is revealing
a large number of similar processes that progress in cells lacking biosynthetic potential. We
believe this proposal can directly test the cause (PTM) and effect (structural change) for at least
one set of these changes, and do so with cell‐level resolution. Successful completion of this
proposal will establish a mechanism by which cells can effect a progression of predictable
structural changes, over time, in the absence of protein synthesis. To do this, we will identify
PTMs, localize them with respect to structural change, then test the effect of the PTM directly by
using CRISPR to genetically modify zebrafish IF PTM sites, and then translate key observation
from zebrafish, into a mouse model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Lens Fiber Cell Structure and Function by Post Translational Modification of Intermediate Filaments
-
批准号:9217353
-
项目类别:
-
资助金额:$39.93万
-
财政年份:2017
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
Non Fiber Cell Functions for the Beaded Filament Proteins
-
批准号:8747592
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2014
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
SDSL-EPR STUDY OF INTERMEDIATE FILAMENT STRUCTURE
-
批准号:7207948
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2006
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
SDSL-EPR STUDY OF INTERMEDIATE FILAMENT STRUCTURE
-
批准号:7582267
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2006
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
SDSL-EPR Study of Intermediate Filament Structure
-
批准号:8236802
-
项目类别:
-
资助金额:$38.43万
-
财政年份:2006
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
SDSL-EPR STUDY OF INTERMEDIATE FILAMENT STRUCTURE
-
批准号:7386600
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2006
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
SDSL-EPR STUDY OF INTERMEDIATE FILAMENT STRUCTURE
-
批准号:7769871
-
项目类别:
-
资助金额:$29.22万
-
财政年份:2006
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
SDSL-EPR STUDY OF INTERMEDIATE FILAMENT STRUCTURE
-
批准号:7090181
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2006
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
SDSL-EPR Study of Intermediate Filament Structure
-
批准号:8394915
-
项目类别:
-
资助金额:$36.58万
-
财政年份:2006
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
SDSL-EPR Study of Intermediate Filament Structure
-
批准号:8597426
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2006
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
CORE--MICROSCOPIC ANATOMY
-
批准号:6599299
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2002
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
CORE--MICROSCOPIC ANATOMY
-
批准号:6462985
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2001
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
Microscopy and Tissue Processing Core
-
批准号:10004631
-
项目类别:
-
资助金额:$11.29万
-
财政年份:1999
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
Microscopy and Tissue Processing Core
-
批准号:10650726
-
项目类别:
-
资助金额:$11.37万
-
财政年份:1999
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
PHASE I-II STUDY OF 131I LABELED MIBG FOR TREATMENT OF PHEOCHROMOCYTOMA
-
批准号:6308669
-
项目类别:
-
资助金额:$2.58万
-
财政年份:1999
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
Microscopy and Tissue Processing Core
-
批准号:10439846
-
项目类别:
-
资助金额:$11.37万
-
财政年份:1999
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
Microscopy and Tissue Processing Core
-
批准号:10246342
-
项目类别:
-
资助金额:$11.37万
-
财政年份:1999
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
CORE--MICROSCOPIC ANATOMY
-
批准号:6156724
-
项目类别:
-
资助金额:$11.85万
-
财政年份:1999
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
PHASE I-II STUDY OF 131I LABELED MIBG FOR TREATMENT OF PHEOCHROMOCYTOMA
-
批准号:6280879
-
项目类别:
-
资助金额:$2.39万
-
财政年份:1997
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
MOLECULAR ANALYSIS OF OCULAR LENS BEADED FILAMENTS
-
批准号:6179097
-
项目类别:
-
资助金额:$36.96万
-
财政年份:1990
-
负责人:PAUL Gillespie FITZGERALD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: